Advertisement
Home 2018 September

Monthly Archives: September 2018

Untreated gestational diabetes is associated with development of subsequent glucose metabolism disorders in mothers

Gestational Diabetes Tied to Subsequent Glucose Disorders

0
Long-term effects seen in mothers, but offspring not significantly overweight, obese
On average

Hospitals Charge 479 Percent of Cost of Drugs on Average

0
Seventeen percent of hospitals charge 700 percent of cost; 8 percent have markup over 1,000 percent
Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or anthracyclines for the treatment of breast cancer

Cardiac Monitoring Needed for High-Risk Breast Cancer Patients

0
Trastuzumab, certain chemo treatments increase patient risk of heart failure
Although there are many demands on residents

Residents Should Take Advantage of Paid Time Off

0
Residents report making time for family, pursuing interests, and squeezing in important trips
Preoperative statin therapy is associated with higher long-term survival following abdominal aortic aneurysm repair

Statins Improve Long-Term Survival After AAA Repair

0
Findings in those taking statins before abdominal aortic aneurysm repair or initiating before discharge
A lawsuit filed Tuesday in California claims that pharmaceutical company AbbVie used cash

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

0
Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient
Compared with intramuscular pethidine

Patient-Directed IV Remifentanil Cuts Epidural Conversions

0
Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine
In an American Academy of Pediatrics policy statement published online Sept. 17 in Pediatrics

Pediatricians Have Role in Supporting Transgender Youth

0
Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse
Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge

No Clear Benefit for Rivaroxaban After Hospital Discharge

0
Incidence of major bleeding low with rivaroxaban, but clot risk not lower
Medicaid expansion was associated with gains in insurance among low-income adults with substance use disorders

Medicaid Expansion Linked to Gains in Insurance Coverage

0
But no corresponding increase in treatment of substance use disorders among low-income adults